What is NAGE's pharmaceuticals segment — net sales?

NAGE (NAGE) reported pharmaceuticals segment — net sales of $0 in Q1 2026.

What does pharmaceuticals segment — net sales mean?

Represents the total revenue generated from the sale of pharmaceutical products within this specific business segment after deducting returns, allowances, and discounts. It serves as the primary indicator of the segment's market demand and commercial success. Tracking this metric helps investors evaluate the revenue-generating capacity of the company's pharmaceutical portfolio.

NAGE NAGE Pharmaceuticals segment — Net Sales

Other segment segments

Consumer Products segment

$22.41M+4.2%

Ingredients segment

$8.56M+4.8%

Analytical Reference Standards and Services segment

$423K-47.8%

Corporate and other

$74K—

Similar metrics at other companies

BAXPharmaceuticals — Net Sales

$621M+6.9%

KNSAPharmaceutical — Revenue

$214.27M+55.5%

VRTXPharmaceuticals — Product revenues, net

$2.99B+7.8%

BCRXProduct sales, net — Total revenues

$151.4M+5.3%

MIRMProduct sales, net — Product sales, net

$159.88M+43.3%

ATRPharma — Net Sales

$438.91M+7.1%

Other financials

Income statement

See full

Revenue$31.5M+3.3%

Gross profit$20.0M+3.3%

Operating income$1.6M-67.0%

Net income$6.3M+24.8%

EPS (diluted)$0.07+16.7%

Balance sheet

See full

Cash & equivalents$66.5M+19.7%

Total debt$2.6M-26.9%

Total equity$82.3M+48.8%

Total assets$114.3M+40.6%

Cash flow

See full

Operating cash flow-$1.2M-115%

Valuation

See full

Market cap$254.07M-74.9%

Enterprise value$190.09M-79.7%

P/E13.6×-43.5×

P/S2×-6.8×

Profitability

See full

Gross margin64.3%+1.8pp

Operating margin10%-2.2pp

Net margin14.3%+1.2pp

FCF margin-70.4%—

Returns & leverage

See full

Return on equity27.1%-6.4pp

Debt / equity0×0.0×

Current ratio4.6×+0.9×

Where this comes from

Reported directly by NAGE in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's pharmaceuticals segment — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NAGE's pharmaceuticals segment — net sales?: NAGE (NAGE) reported pharmaceuticals segment — net sales of $0 in Q1 2026.
What does pharmaceuticals segment — net sales mean?: Represents the total revenue generated from the sale of pharmaceutical products within this specific business segment after deducting returns, allowances, and discounts. It serves as the primary indicator of the segment's market demand and commercial success. Tracking this metric helps investors evaluate the revenue-generating capacity of the company's pharmaceutical portfolio.